🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ticiana Leal

Emory University

ORCID: 0000-0002-3735-9063

Also affiliated with Emory University Hospital, Cancer Institute (WIA), Piedmont Cancer Institute, Winship Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 13 papers. Top paper: “Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study”.

Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study

The Lancet Oncology(2023)10.1016/s1470-2045(23)00344-3
N/A
3.1DataRank · unranked
105 citations

Rupesh Kotecha, Rodryg Ramlau, Li Zhang, Janusz Milanowski, Manuel Cobo +20 more

Patient‐reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial

Cancer Medicine(2020)10.1002/cam4.3416
N/A
0.523DataRank · unranked
9 citations

Fengmin Zhao, Taofeek K. Owonikoko, Josephine Feliciano, Nisha Mohindra, Suzanne E. Dahlberg +10 more

Analytical validation and initial clinical testing of quantitative microscopic evaluation for PD-L1 and HLA I expression on circulating tumor cells from patients with non-small cell lung cancer

Biomarker Research(2022)10.1186/s40364-022-00370-8
N/A
0DataRank · unranked
7 citations

Nan Sethakorn, Zachery D. Schultz, Camila I. Hernandez, Rory M. Bade, Diego Eyzaguirre +10 more

Determining Biomarkers of Myosteatosis for Sarcopenia and Cachexia Using MRI and Ultrasound

The FASEB Journal(2022)10.1096/fasebj.2022.36.s1.r3951
N/A
0DataRank · unranked
1 citations

Jevin Lortie, Katie Osterbauer, Sujay Garlapati, Toby C. Campbell, Anne M. Traynor +5 more

Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase 1b Trial

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.11.040
N/A
0DataRank · unranked
16 citations

Brett Morris, Nan Sethakorn, Joshua M. Lang, Jennifer L. Schehr, Shuang G. Zhao +9 more

Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non–small cell lung cancer

Cancer(2023)10.1002/cncr.34915
N/A
0DataRank · unranked
3 citations

James Janopaul‐Naylor, Hamilton S. McGinnis, Aparna H. Kesarwala, Sibo Tian, William Stokes +8 more

Consolidation Osimertinib Versus Durvalumab Versus Observation After Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC: A Multicenter Retrospective Cohort Study

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.01.012
N/A
0DataRank · unranked
42 citations

So Yeon Kim, Jacqueline V. Aredo, Jamie Feng, Frances A. Shepherd, Chao Xu +52 more

DNA topoisomerase II inhibition potentiates osimertinib’s therapeutic efficacy in EGFR-mutant non–small cell lung cancer models

Journal of Clinical Investigation(2024)10.1172/jci172716
N/A
0DataRank · unranked
30 citations

Karin A. Vallega, Dongsheng Wang, Zihan Quan, Songqing Fan, Qiming Wang +4 more

Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancer

The Journal of Experimental Medicine(2024)10.1084/jem.20240435
N/A
0DataRank · unranked
15 citations

Karin A. Vallega, Dongsheng Wang, Zihan Quan, Songqing Fan, Qiming Wang +4 more

Sotorasib for the treatment of locally advanced/metastatic non-small cell lung cancer

Future Oncology(2024)10.1080/14796694.2024.2430172
N/A
0DataRank · unranked
4 citations

Jennifer W. Carlisle, Nader H. Moniri, Shruti Gupta, Eziafa Oduah, Ticiana Leal +1 more

Uncorrected and subcutaneous fat‐corrected echo intensities are similarly associated with magnetic resonance imaging per cent fat

JCSM Communications(2024)10.1002/rco2.92
N/A
0DataRank · unranked
1 citations

Sujay Garlapati, Jevin Lortie, Katie Osterbauer, Timothy J. Colgan, Daiki Tamada +7 more

The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR study

Lung Cancer(2025)10.1016/j.lungcan.2025.108802
N/A
0DataRank · unranked
1 citations

David E. Gerber, Rupesh Kotecha, Jeffrey P. Ward, Wallace Akerley, Lukas Weiß +5 more

Myosteatosis as a Shared Biomarker for Sarcopenia and Cachexia Using MRI and Ultrasound

Frontiers in Rehabilitation Sciences(2022)10.3389/fresc.2022.896114
N/A
0DataRank · unranked
15 citations

Benjamin Rush, Katie Osterbauer, Timothy J. Colgan, Daiki Tamada, Sujay Garlapati +9 more